Trusted Data in Regulated Industries: A Board Readiness Checklist

Directors do not need to become data scientists, but they can no longer treat data and AI as management detail. Regulators, courts, and shareholders increasingly treat oversight of data governance in regulated industries as a core board duty, on par with financial controls. The uncomfortable part is that most boards are asked to approve AI strategies they have no structured way to interrogate. This checklist gives directors and executives that structure: what trusted data and AI controls look like, the questions to ask management, and the red flags that should stop a meeting.

Why boards now own data and AI oversight

For two decades, data was an operational concern and the board's exposure was indirect. Three shifts ended that. First, regulation caught up: sectoral rules in banking, insurance, and healthcare now speak directly to data quality, model governance, and AI use, and cross-sector regimes such as the EU AI Act extend those expectations to any organization operating in scope. Second, enforcement moved from policy to proof. Examiners ask for data lineage, model inventories, and evidence of testing, and "we have a policy" is no longer a passing answer. Third, the caselaw on director oversight duties keeps expanding into mission-critical operational risks, and for a growing number of firms, data and AI are exactly that.

The practical consequence: when an AI system misprices risk, leaks personal data, or produces a discriminatory outcome, the first questions will be about governance. Who approved the use case? What controls existed? What did the board know, and when? Boards that cannot answer are exposed even when the underlying failure was technical.

What "board ready" actually means

Board readiness is not a binder of policies. It is the ability of management to answer four questions with evidence, on demand:

1. What do we have? A current inventory of critical data domains, AI systems, and models, including third-party and embedded AI.

2. Who owns it? Named executives and data stewards accountable for each domain and each model, with governance forums that meet and decide.

3. How do we know it is right? Defined quality standards, automated validation, documented lineage, and independent testing proportionate to risk.

4. What happens when it is wrong? Monitoring that catches failures, an incident process that escalates them, and reporting that reaches the board.

If management can answer those four questions for the data and AI behind your most consequential decisions, you are largely ready. The checklist below turns each question into inspectable detail.

The board readiness checklist

1. Accountability and ownership

There is a named executive owner for data (a chief data officer, or a fractional equivalent in smaller organizations). Critical data domains have named stewards. An AI or data governance committee exists, has a charter, meets on a schedule, and records decisions. Board-level responsibility is assigned to a committee, typically audit or risk, with data and AI as a standing agenda item at least twice a year.

2. Data quality controls

The organization has defined its critical data elements, the fields that feed financial reporting, regulatory filings, pricing, and AI models. Each has a documented definition, a quality standard, and automated checks that run continuously rather than at audit time. Quality metrics trend over time and management can show them. Manual spreadsheet-based reconciliation of critical data is the exception, not the process.

3. Lineage and auditability

For high-stakes reports and models, management can trace data from source system to final output, including transformations along the way. When a number is challenged, the organization can reproduce how it was calculated. This is the control that turns "trust us" into "here is the evidence," and it is the single most common gap we find in a data governance checklist review.

4. AI and model inventory

Every model and AI system in production is inventoried, including vendor tools with embedded AI and generative AI used by staff. Each entry records its purpose, owner, data inputs, and risk tier. Higher-tier models receive independent validation before deployment and periodic review after. Generative AI use cases have documented guardrails: what they may be used for, what data may enter them, and who reviews outputs.

5. Privacy and security controls

Personal and sensitive data is classified and mapped to the systems that hold it. Access follows least privilege and is recertified periodically. Retention schedules exist and are enforced. Privacy and security requirements are embedded in the AI lifecycle, so a new use case cannot reach production without a privacy review proportionate to its risk.

6. Third-party and vendor data risk

Data and AI obligations flow into vendor contracts: usage rights, security standards, breach notification, audit rights, and clarity on whether your data trains their models. Critical data suppliers and AI vendors are tiered and monitored like other material third parties. Concentration risk, one vendor behind many critical processes, is known and reported.

7. Incident readiness and board reporting

There is a defined process for data and AI incidents: quality failures, model errors, privacy breaches, misuse of generative tools. Escalation thresholds are written down, so the board hears about material incidents from management rather than the press. Board reporting includes a small set of standing metrics: quality trends for critical data, inventory coverage, validation backlog, incidents and their resolution.

The regulatory landscape, briefly

Directors do not need the full taxonomy, but four reference points anchor the conversation. In banking, supervisory guidance on model risk management (SR 11-7 in the United States and its analogues elsewhere) and the BCBS 239 principles on risk-data aggregation set long-standing expectations for data quality, lineage, and reporting that examiners now apply to AI-adjacent systems. In insurance and healthcare, sectoral rules tie data handling directly to solvency reporting and patient privacy, with HIPAA enforcement increasingly focused on access controls and vendor arrangements. State-level regimes such as NYDFS cybersecurity requirements make board reporting on data protection explicit. And the EU AI Act, phasing in through 2026 and 2027, introduces binding obligations, risk classification, documentation, human oversight, post-market monitoring, for organizations deploying higher-risk AI in scope, regardless of where they are headquartered.

The pattern across all of them is convergent: regulators are done asking whether you have a policy. They ask what you have, who owns it, how you test it, and how the board is informed. That is exactly the structure of the checklist above, which is not a coincidence; the checklist is the regulation's common denominator translated into an agenda.

What good board reporting looks like

Most data and AI reporting to boards fails in one of two directions: a strategy narrative with no numbers, or a metrics appendix with no meaning. The workable middle is a one-page standing report with four sections. Coverage: what share of critical data domains and production AI systems are inventoried, owned, and under automated quality control, with trend. Health: the quality and monitoring metrics for the highest-stakes domains, shown against thresholds rather than as raw figures. Exposure: open findings, aging validation backlog, material incidents since last report and their remediation status. Change: new AI use cases approved, vendor changes, and regulatory developments that alter the risk picture. Twenty minutes twice a year on that page, with the same structure every time, builds more genuine oversight than an annual deep-dive presentation.

Ten questions directors should ask management

Use these in the next board or committee meeting. The goal is not to catch anyone out; it is to establish whether the four readiness questions have evidence behind them.

1. Which ten data domains matter most to our strategy and our regulatory obligations, and who owns each one?

2. What percentage of our critical data elements have automated quality checks, and what is the trend?

3. Can we trace our most scrutinized regulatory report back to source data today? How long would it take to demonstrate?

4. How many models and AI systems are in production, and how many have never been independently validated?

5. Where is generative AI being used in the business today, sanctioned or not, and what controls apply?

6. Which vendors hold or process our critical data, and do our contracts prevent them from training models on it?

7. What data or AI incidents occurred in the last year, and what changed as a result?

8. If our primary data platform failed tomorrow, how would we know which downstream decisions were affected?

9. What would an examiner find if they asked for our AI governance framework this quarter?

10. What investment would move us from where we are to defensible, and what is the cost of not making it?

Red flags that should stop the meeting

Certain answers signal that risk is being carried unpriced. No named owner for data. An AI inventory that management must assemble after the question is asked. Quality checks that exist only where auditors have already looked. Generative AI "not in use" in an organization of hundreds of people, which almost always means unmonitored use. Vendor contracts no one has read for AI clauses. Board reporting on data and AI that consists of a strategy slide rather than metrics.

How to get ready in 30 days

Readiness does not require a multi-year transformation to begin. A focused assessment can establish the baseline in about a month: identify the top data domains and AI use cases by consequence, test the four readiness questions against each, document gaps against the seven checklist domains, and put a remediation plan with owners and dates in front of the board. From there, the standing metrics and the twice-yearly agenda item keep it alive. Our guide to building trust in AI through data governance covers the operating discipline that sits underneath this checklist, and our note on model risk in the age of generative AI goes deeper on the model inventory and validation domain.

Frequently asked questions

What should a board ask about AI governance?

Start with four questions: what AI systems and data do we have, who owns them, how do we know they work as intended, and what happens when they fail. Evidence-backed answers to those four cover most regulatory expectations.

Which board committee should own data and AI oversight?

Most boards assign it to the audit or risk committee, with the full board reviewing strategy annually. What matters is that ownership is explicit, the topic recurs on the agenda, and reporting includes metrics rather than assurances.

How often should boards review data and AI controls?

At least twice a year as a standing item, plus event-driven reviews after material incidents, major AI deployments, or regulatory changes affecting data governance in regulated industries.

Do these expectations apply to companies that only use vendor AI?

Yes. Regulators treat outsourced AI as your risk. The inventory, contract terms, monitoring, and incident escalation in this checklist apply to embedded and vendor AI just as they do to models built in-house.